» Articles » PMID: 37632914

Store-and-Forward Teledermatology for Assessing Skin Cancer in 2023: Literature Review

Overview
Journal JMIR Dermatol
Specialty Dermatology
Date 2023 Aug 26
PMID 37632914
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The role of teledermatology for skin lesion assessment has been a recent development, particularly, since the COVID-19 pandemic has impacted the ability to assess patients in person. The growing number of studies relating to this area reflects the evolving interest.

Objective: This literature review aims to analyze the available research on store-and-forward teledermatology for skin lesion assessment.

Methods: MEDLINE was searched for papers from January 2010 to November 2021. Papers were searched for assessment of time management, effectiveness, and image quality.

Results: The reported effectiveness of store-and-forward teledermatology for skin lesion assessment produces heterogeneous results likely due to significant procedure variations. Most studies show high accuracy and diagnostic concordance of teledermatology compared to in-person dermatologist assessment and histopathology. This is improved through the use of teledermoscopy. Most literature shows that teledermatology reduces time to advice and definitive treatment compared to outpatient clinic assessment.

Conclusions: Overall, teledermatology offers a comparable standard of effectiveness to in-person assessment. It can save significant time in expediting advice and management. Image quality and inclusion of dermoscopy have a considerable bearing on the overall effectiveness.

Citing Articles

Teledermatology viewpoint: Sudden onset of a widespread rash.

Bernat A, Brodell R, Dolohanty L JAAD Case Rep. 2025; 57:56-58.

PMID: 40027432 PMC: 11869946. DOI: 10.1016/j.jdcr.2024.10.034.


Revolutionizing Skin Cancer Triage: The Role of Patient-Initiated Teledermoscopy in Remote Diagnosis.

Foltz E, Ludzik J, Leachman S, Stoos E, Greiling T, Teske N Cancers (Basel). 2024; 16(14).

PMID: 39061204 PMC: 11274391. DOI: 10.3390/cancers16142565.


Telehealth With Comprehensive Live-Fed Real-World Data as a Patient Care Platform for Lung Cancer: Implementation and Evaluation Study.

Zheng D, Shang Y, Ni J, Peng L, Tan X, Dai Z JMIR Cancer. 2024; 10:e45331.

PMID: 38838304 PMC: 11187506. DOI: 10.2196/45331.


Direct-to-Patient Mobile Teledermoscopy: Prospective Observational Study.

Fan W, Mattson G, Twigg A JMIR Dermatol. 2024; 7:e52400.

PMID: 38345831 PMC: 10897786. DOI: 10.2196/52400.


Barriers and Facilitators to Teledermatology and Tele-Eye Care in Department of Veterans Affairs Provider Settings: Qualitative Content Analysis.

Li Y, Pope C, Damonte J, Spates T, Maa A, Chen S JMIR Dermatol. 2024; 7:e50352.

PMID: 38324360 PMC: 10882469. DOI: 10.2196/50352.

References
1.
Arzberger E, Curiel-Lewandrowski C, Blum A, Chubisov D, Oakley A, Rademaker M . Teledermoscopy in High-risk Melanoma Patients: A Comparative Study of Face-to-face and Teledermatology Visits. Acta Derm Venereol. 2016; 96(6):779-83. DOI: 10.2340/00015555-2344. View

2.
Lowe A, Atwan A, Mills C . Teledermoscopy as a community based diagnostic test in the era of COVID-19?. Clin Exp Dermatol. 2021; 46(1):173-174. PMC: 9213904. DOI: 10.1111/ced.14399. View

3.
Sunderland M, Teague R, Gale K, Rademaker M, Oakley A, Martin R . E-referrals and teledermatoscopy grading for melanoma: a successful model of care. Australas J Dermatol. 2020; 61(2):147-151. DOI: 10.1111/ajd.13230. View

4.
Greenwald E, Tan A, Stein J, Liebman T, Bowling A, Polsky D . Real-world outcomes of melanoma surveillance using the MoleMap NZ telemedicine platform. J Am Acad Dermatol. 2020; 85(3):596-603. DOI: 10.1016/j.jaad.2020.02.057. View

5.
Kroemer S, Fruhauf J, Campbell T, Massone C, Schwantzer G, Soyer H . Mobile teledermatology for skin tumour screening: diagnostic accuracy of clinical and dermoscopic image tele-evaluation using cellular phones. Br J Dermatol. 2011; 164(5):973-9. DOI: 10.1111/j.1365-2133.2011.10208.x. View